Tempus Health: Restoring Healthcare to the American People — Eric Lefkofsky

Tempus’ flagship product, the Living Test™ Engine, is a suite of bioinformatics tools designed to collect data and to train and optimize the Living Test Engine’s predictive algorithm. It is led by Eric Lefkofsky. Predictive algorithms are used at the Living Test Engine to identify treatment pathways based on a variety of factors, including, but not limited to, patient characteristics, historical treatment responses, and risk profiles. The Living Test Engine predicts these treatment pathways with exceptional accuracy in a wide range of patient settings, including clinical trials. 


Tempus is powered by the largest collection of healthcare data in the world and is built on a deep understanding of clinical biology. Under the leadership of Eric Lefkofsky, Tempus has developed new ways of organizing clinical and molecular data into hierarchical and adaptive information systems. 

 

This approach allows doctors and researchers to see connections within large data sets and discover potential new treatments and outcomes. “This is our legacy,” said Eric Lefkofsky. “It is a big bet. We have spent the last decade on medical research and on integrating into our platform industry leaders who are solving complex problems that not only help patients and physicians but also help the health care system itself.” 

Tempus’ commitment to improving clinical care begins with their proprietary computer algorithm, LIMS, a scalable, cloud-based operating system that brings in the data needed to perform precision medicine, regardless of how it’s been used and built into the LIMS software. Tempus, Eric Lefkofsky finally states, is focused on building tools that accelerate human evolution and make a profound impact on healthcare. Tempus’s vision is to create technology and systems that help change the way healthcare is delivered by empowering clinicians to be more accurate in their care.